Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rafael Arroyo

Showing results (111-120 of 116) with videos related to

Pageof 12
Sort By:
You have reached the last page of results.This site can display upto 116 results.
Revista De Neurologia|September 21, 2013
Review of the novelties presented at the 28th Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) (III)Óscar Fernández, Carmen Arnal-García, Rafael Arroyo-González, et al.
Human Molecular Genetics|July 9, 2015
A functional variant that affects exon-skipping and protein expression of SP140 as genetic mechanism predisposing to multiple sclerosisFuencisla Matesanz, Victor Potenciano, Maria Fedetz, et al.
Therapeutic Advances in Neurological Disorders|November 1, 2024
Beyond lines of treatment: embracing early high-efficacy disease-modifying treatments for multiple sclerosis managementCelia Oreja-Guevara, Sergio Martínez-Yélamos, Sara Eichau, et al.
Annals of Neurology|January 13, 2015
Lipid-specific immunoglobulin M bands in cerebrospinal fluid are associated with a reduced risk of developing progressive multifocal leukoencephalopathy during treatment with natalizumabLuisa M Villar, Lucienne Costa-Frossard, Thomas Masterman, et al.
G3 (Bethesda, Md.)|May 20, 2016
Analysis of Plasminogen Genetic Variants in Multiple Sclerosis PatientsA Dessa Sadovnick, Anthony L Traboulsee, Cecily Q Bernales, et al.
Frontiers in Neurology|January 7, 2021
New Algorithms Improving PML Risk Stratification in MS Patients Treated With NatalizumabInmaculada Toboso, Amalia Tejeda-Velarde, Roberto Alvarez-Lafuente, et al.
Pageof 12

Showing results (111-120 of 116) with videos related to

Sort By:
Pageof 12
You have reached the last page of results.This site can display upto 116 results.
Revista De Neurologia|September 21, 2013
Review of the novelties presented at the 28th Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) (III)Óscar Fernández, Carmen Arnal-García, Rafael Arroyo-González, et al.
Human Molecular Genetics|July 9, 2015
A functional variant that affects exon-skipping and protein expression of SP140 as genetic mechanism predisposing to multiple sclerosisFuencisla Matesanz, Victor Potenciano, Maria Fedetz, et al.
Therapeutic Advances in Neurological Disorders|November 1, 2024
Beyond lines of treatment: embracing early high-efficacy disease-modifying treatments for multiple sclerosis managementCelia Oreja-Guevara, Sergio Martínez-Yélamos, Sara Eichau, et al.
Annals of Neurology|January 13, 2015
Lipid-specific immunoglobulin M bands in cerebrospinal fluid are associated with a reduced risk of developing progressive multifocal leukoencephalopathy during treatment with natalizumabLuisa M Villar, Lucienne Costa-Frossard, Thomas Masterman, et al.
G3 (Bethesda, Md.)|May 20, 2016
Analysis of Plasminogen Genetic Variants in Multiple Sclerosis PatientsA Dessa Sadovnick, Anthony L Traboulsee, Cecily Q Bernales, et al.
Frontiers in Neurology|January 7, 2021
New Algorithms Improving PML Risk Stratification in MS Patients Treated With NatalizumabInmaculada Toboso, Amalia Tejeda-Velarde, Roberto Alvarez-Lafuente, et al.
Pageof 12